No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Dosimetry characterization of a multibeam radiotherapy treatment for age-related macular degeneration
1.H. Churei, K. Ohkubo, M. Nakajo, H. Hokotate, Y. Baba, J. Ideue, K. Miyagawa, H. Nakayama, Y. Hiraki, T. Kitasato, and N. Yabe, “External-beam radiation therapy for age-related macular degeneration: two years’ follow-up results at a total dose of in 10 fractions,” Radiat. Med. 22, 398–404 (2004).
2.R. P. Murphy, “Age-related macular degeneration,” Ophthalmology 93, 969–971 (1986).
3.N. M. Bressler, S. B. Bressler, and S. L. Fine, “Age-related macular degeneration,” Surv. Ophthalmol. 32, 375–413 (1988).
4.B. Morris, F. Imrie, A. M. Armbrecht, and B. Dhillon, “Age-related macular degeneration and recent developments: new hope for old eyes?,” Postgrad Med. J. 83, 301–307 (2007).
5.Macular Photocoagulation Study Group, “Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity,” Arch. Ophthalmol. (Chicago) 112, 480–488 (1994).
6.VPT Study Group, “Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. results of a randomized clinical trial--VIP report no. 1,” Ophthalmology 108, 841–852 (2001).
7.P. J. Rosenfeld, D. M. Brown, J. S. Heier, D. S. Boyer, P. K. Kaiser, C. Y. Chung, and R. Y. Kim, “Ranibizumab for neovascular age-related macular degeneration,” N. Engl. J. Med. 355, 1419–1431 (2006).
8.A. Capone and Macugen AMD Study Group, “Intravitreous pegaptanib sodium (Macugen) in patients with age-related macular degeneration (AMD): Safety and pharmacokinetics,” Invest. Ophthalmol. Visual Sci. (Annual Meeting Abstracts) Online 46, E-Abstract 2362 (2005).
9.I. Crocker, T. Ciulla, E. Butker, G. Burian, and B. Hubbard, “Initial experience with Therasight ocular brachytherapy system for treatment of ARMD,” Radiother. Oncol. 75, S58–S59 (2005).
10.G. Hubbard, S. Carr, K. Millage, and R. Waldron, “Cadaver evaluation of a new ocular brachytherapy system,” Invest. Ophthalmol. Visual Sci. 45, 5139 (2004).
11.J. S. Heier, “Concomitant therapy of epiretinal radiation and bevacizumab for neovascular AMD,” in 2007 Annual Meeting of the American Academy of Opthalmology, New Orleans, LA (2007).
12.H. J. Zambarakji, A. M. Lane, E. Ezra, D. Gauthier, M. Goitein, J. A. Adams, J. E. Munzenrider, J. W. Miller, and E. S. Gragoudas, “Proton beam irradiation for neovascular age-related macular degeneration,” Ophthalmology 113, 2012–2019 (2006).
13.A. Haas, G. Papaefthymiou, G. Langmann, O. Schrottner, B. Feigl, K. A. Leber, R. Hanselmayer, and G. Pendl, “Gamma knife treatment of subfoveal, classic neovascularization in age-related macular degeneration: a pilot study,” J. Neurosurg. 93, 172–176 (2000).
14.M. Hayashi, M. Chernov, M. Usukura, K. Abe, Y. Ono, M. Izawa, S. Hori, T. Hori, and K. Takakura, “Gamma knife surgery for choroidal neovascularization in age-related macular degeneration. Technical note,” J. Neurosurg. 102, 200–203 (2005).
15.M. A. Henderson, S. Valluri, S. S. Lo, T. C. Witt, R. M. Worth, R. P. Danis, and R. D. Timmerman, “Gamma knife radiosurgery in the treatment of choroidal neovascularization (wet-type macular degeneration),” Stereotact. Funct. Neurosurg. 85, 11–17 (2007).
16.D. M. Marcus, E. Peskin, M. Maguire, D. Weissgold, J. Alexander, S. Fine, and D. Followill, “The age-related macular degeneration radiotherapy trial (AMDRT): One year results from a pilot study,” Am. J. Ophthalmol. 138, 818–828 (2004).
17.RAD Study Group, “A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration,” Ophthalmology 106, 2239–2247 (1999).
18.S. V. Goverdhan, F. A. Gibbs, and A. J. Lotery, “Radiotherapy for age-related macular degeneration: no more pilot studies please,” Eye 19, 1137–1141 (2005).
19.F. Schwarz and D. Christie, “Use of ‘sham’ radiotherapy in randomized clinical trials,” J Med Imaging Radiat Oncol 52, 269–277 (2008).
20.NCRP, “Biological effects and exposure limits for hot particles,” Report No. 130, National Council on Radiation Protection and Measurements, Bethesda, MD (1999).
21.C. A. Girkin, C. H. Comey, L. D. Lunsford, M. L. Goodman, and L. B. Kline, “Radiation optic neuropathy after stereotactic radiosurgery,” Ophthalmology 104, 1634–1643 (1997).
22.S. L. Stafford, B. E. Pollock, J. A. Leavitt, R. L. Foote, P. D. Brown, M. J. Link, D. A. Gorman, and P. J. Schomberg, “A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery,” Int. J. Radiat. Oncol., Biol., Phys. 55, 1177–1181 (2003).
23.R. P. Singh, D. Moshfeghi, E. M. Shusterman, S. A. McCormick, and M. Gernter, “Evaluation of transconjunctival collimated external beam radiation for age-related macular degeneration (ARMD) [abstract],” in 2008 Annual Meeting of the American Academy of Opthalmology, Atlanta, GA, 2008, pp. 08-PP-30018701-AAO.
24.D. B. Pelowitz, MCNPX User’s Manual Version 2.5.0, LA-CP-05-0369. (Los Alamos National Laboratory, Los Alamos, NM, 2005).
25.K. Cranley, B. J. Gilmore, G. W. A. Fogarty, and L. Desponds, “Catalogue of diagnostic x-ray spectra and other data,” Report No. 78, The Institute of Physics, London, UK 1997.
26.M. Cristy and K. F. Eckerman, “Specific absorbed fractions of energy at various ages from internal photon sources,” ORNL/TM-8381/Volumes I-VII, Oak Ridge National Laboratory, Oak Ridge, TN, 1987.
27.ICRU, “Photon, electron, proton and neutron interaction data for body tissues,” Report No. 46, International Commission on Radiation Units and Measurements, Bethesda, MD, 1992.
28.R. Unsold, J. DeGroot, and T. H. Newton, “Images of the optic nerve: anatomic-CT correlation,” AJR, Am. J. Roentgenol. 135, 767–773 (1980).
29.C. Lee, C. Lee, D. Lodwick, and W. E. Bolch, “NURBS-based 3D anthropometric computational phantoms for radiation dosimetry applications,” Radiat. Prot. Dosim. 127, 227–232 (2007).
30.C. Lee, D. Lodwick, J. L. Williams, and W. E. Bolch, “Hybrid computational phantoms of the male and female adolescent: applications to CT organ dosimetry for patients of variable morphometry,” Med. Phys. 35, 2366–2382 (2008).
Article metrics loading...
Full text loading...
Most read this month